ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 181 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $751,942 | +27.2% | 67,318 | +143.7% | 0.10% | +17.3% |
| Q2 2023 | $591,047 | +7.9% | 27,619 | +138.2% | 0.08% | +68.8% |
| Q2 2022 | $548,000 | -25.5% | 11,597 | -10.5% | 0.05% | -9.4% |
| Q3 2021 | $736,000 | -27.0% | 12,954 | -43.4% | 0.05% | -20.9% |
| Q2 2021 | $1,008,000 | +3.4% | 22,900 | +15.9% | 0.07% | -4.3% |
| Q1 2021 | $975,000 | -3.1% | 19,763 | -17.3% | 0.07% | +2.9% |
| Q4 2020 | $1,006,000 | +13.3% | 23,900 | +23.2% | 0.07% | +15.3% |
| Q3 2020 | $888,000 | -38.9% | 19,400 | -33.0% | 0.06% | -40.4% |
| Q2 2020 | $1,453,000 | +198.4% | 28,942 | +114.6% | 0.10% | +800.0% |
| Q3 2015 | $487,000 | +73.3% | 13,485 | +116.0% | 0.01% | +57.1% |
| Q2 2015 | $281,000 | -34.8% | 6,242 | -55.6% | 0.01% | -36.4% |
| Q1 2015 | $431,000 | – | 14,068 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |